Topics

FDA approves first drug for treatment of peanut allergy for children

12:12 EST 31 Jan 2020 | FDA

FDA approves first drug for treatment of peanut allergy for children
Treatment with this product may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued in individuals 4 years of age and older.

Original Article: FDA approves first drug for treatment of peanut allergy for children

NEXT ARTICLE

More From BioPortfolio on "FDA approves first drug for treatment of peanut allergy for children"

Quick Search